What one share of Regenerative Medical Technology Group holds
Our mission is to empower physicians globally to deliver the transformative benefits of regenerative medicine—stem cell therapies, exosomes, peptides, and advanced combination protocols—to patients seeking effective, natural alternatives to traditional surgical, palliative, or symptom-management approaches.
Regenerative Medical Technology Group’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.73 |
|---|---|
| Profit | −$0.68 |
| Capex (buildings and equipment) | $0.07 |
| Free cash flow | −$0.04 |
| Cash and investments | $0.10 |
| Debt | $0.15 |
| Book value | −$2.86 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $0.01 | −$0.11 | — | — | — | −$0.68 |
| 2018 | $0.01 | −$0.50 | $0.00 | −$0.06 | — | −$0.93 |
| 2019 | $0.01 | −$0.47 | $0.02 | −$0.09 | — | −$0.92 |
| 2020 | $0.01 | −$0.63 | $0.01 | −$0.05 | — | −$0.59 |
| 2021 | $0.04 | −$1.12 | — | — | — | −$0.56 |
| 2022 | $0.13 | −$0.45 | $0.02 | −$0.11 | — | −$0.96 |
| 2023 | $0.19 | −$0.79 | $0.03 | −$0.06 | — | −$1.74 |
| 2024 | $0.33 | −$0.44 | $0.02 | $0.05 | — | −$2.18 |
| 2025 | $0.40 | −$0.62 | $0.05 | −$0.10 | — | −$2.64 |
Common questions about Regenerative Medical Technology Group
How much does one share of Regenerative Medical Technology Group earn?
Over the last 12 months, Regenerative Medical Technology Group lost $0.68 for each share on $0.73 of sales.
Does Regenerative Medical Technology Group pay a dividend?
Regenerative Medical Technology Group didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Regenerative Medical Technology Group’s book value per share?
Regenerative Medical Technology Group’s book value is negative (−$2.86 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Regenerative Medical Technology Group have?
Each share of Regenerative Medical Technology Group has $0.10 of cash and investments and $0.15 of debt, as of June 30, 2026.
What is Regenerative Medical Technology Group’s free cash flow per share?
−$0.04 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Regenerative Medical Technology Group bought back shares?
Regenerative Medical Technology Group’s share count rose about 264% from 2017 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.